December 20, 2023 — Terran Biosciences, Inc., a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric illnesses, has received U.S. Food and Drug Administration (FDA) clearance to market NM-101, a cloud-based software platform to analyze neuromelanin-sensitive MRI scans.

December 19, 2023 — Prostate cancer patients treated at Advanced Radiation Centers of New York (ARC) became the first in the United States to benefit from the implantation of a novel biodegradable rectal spacer – The BioProtect Balloon Implant System. These pioneering implant procedures were performed by Dr. Shawn H. Zimberg, Medical Director at ARC, a division of Integrated Medical Professionals (IMP).

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro.Pulse, a dual-source computed tomography scanner designed to be more affordable for a wide range of healthcare facilities, including outpatient diagnostic centers.

December 18, 2023 — SyntheticMR announced that its next-generation imaging solution with isotropic 3D resolution, SyMRI 3D, has obtained approval in the EU and is now CE-Marked. With preparations in place, SyntheticMR eagerly anticipates the commercial launch of SyMRI 3D at the start of 2024.

December 18, 2023 —